Valuation: OrthoPediatrics Corp.

Market Cap 504M 443M 408M 381M 715M 47.55B 728M 4.89B 1.9B 23.44B 1.89B 1.85B 81.46B P/E 2026 *
-16.8x
P/E 2027 * -24.5x
Enterprise Value 504M 443M 408M 381M 715M 47.55B 728M 4.89B 1.9B 23.44B 1.89B 1.85B 81.46B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.7x
Free-Float
67.15%
Yield 2026 *
-
Yield 2027 * -
1 day+0.79%
1 week+8.20%
Current month+14.44%
1 month+9.78%
3 months+20.18%
6 months+13.32%
Current year+10.64%
1 week 18.07
Extreme 18.07
20
1 month 16.39
Extreme 16.39
20
Current year 14.42
Extreme 14.42
20.34
1 year 14.42
Extreme 14.42
23.7
3 years 14.42
Extreme 14.42
45.96
5 years 14.42
Extreme 14.42
73.91
10 years 14
Extreme 14.0001
73.91
Manager TitleAgeSince
Chief Executive Officer 47 03/06/2021
Director of Finance/CFO 58 01/02/2015
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 47 03/11/2021
Chairman 75 03/06/2021
Director/Board Member 70 01/01/2011
Date Insider Type Main position Quantity % Market Cap.
06-09Free

Director

11,436 0.0445%
06-09Free

Director

11,436 0.0445%
06-09Free

Director

11,436 0.0445%
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+8.20%-9.74%-54.50% 504M
+3.71%+6.08%-17.21%+8.88% 121B
-0.65%+0.89%+3.09%-8.39% 12.85B
-0.94%+8.65%+41.04%+107.21% 8.37B
+0.95%-2.64%-48.91%-71.79% 3.95B
-0.83%-0.59%+17.21%+37.73% 2.53B
+3.08%+21.07%+250.54%+185.59% 1.7B
-5.16%-4.93%-20.70%-17.36% 1.68B
-0.87%-0.70%-0.12%-20.99% 1.57B
Average +0.02%+2.56%+23.91%+18.48% 17.15B
Weighted average by Cap. +2.75%+2.75%-9.50%+12.33%

Financials

2026 *2027 *
Net sales 265M 233M 215M 201M 376M 25.01B 383M 2.57B 997M 12.33B 995M 974M 42.85B 297M 260M 240M 224M 421M 27.98B 429M 2.88B 1.12B 13.79B 1.11B 1.09B 47.93B
Net income -26.4M -23.19M -21.37M -19.98M -37.47M -2.49B -38.16M -256M -99.31M -1.23B -99.16M -96.98M -4.27B -17.65M -15.51M -14.29M -13.36M -25.06M -1.67B -25.52M -171M -66.4M -821M -66.3M -64.84M -2.85B
Net Debt - -
Logo OrthoPediatrics Corp.
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Employees
602
Date Price Change Volume
26/06/26 $19.83 +1.04% 40,830
25/06/26 $19.62 +2.51% 148,164
24/06/26 $19.14 +4.16% 200,355
23/06/26 $18.38 +1.18% 130,394
22/06/26 $18.16 -3.76% 61,207
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
19.62USD
Average target price
24.67USD
Spread / Average Target
+25.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KIDS Stock